For the chiral analytical HPLC a Thermo Separation Products system equipped with a UV-6000 detector, a P-4000 pump and a Daicel Chiralpak 10 µm column (C18; 250 × 4.60 mm) was used. A flow rate of 1 mL min −1 using an eluent consisting of hexane/isopropanol (9/1) was employed (method M4).
MALDI-TOF mass spectra were measured on a Voyager DE Instrument (PE Biosystems, Weiterstadt, Germany) mounted with a 1.2 m flight tube. 2,5-Dihydroxybenzoic acid was used as the matrix. Depending on the mass range the ions were accelerated at 15 to 25 kV with the option of detecting positive or negative ions. The instrument default calibration was used for calibrating the mass axis.
ESI experiments were performed on a Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass spectrometer APEX III (Bruker Daltonik, Bremen, Germany) equipped 5
General procedure GP2 -Macrolactamization
After addition of absolute piperidine (5.0 equiv) at room temperature to a solution of the acyclic depsipeptide (1.0 equiv in absolute DMF, 30 mL/mmol), the reaction mixture was stirred overnight in the dark, and the conversion was monitored by TLC.
Subsequently, the reaction mixture was diluted with ethyl acetate (300 mL/mmol) and washed with H 2 O (400 mL/mmol). The aqueous phase was extracted with ethyl acetate (3 × 200 mL/mmol) and the combined organic layers were washed with brine (100 mL/mmol), dried over MgSO 4 and evaporated to dryness in vacuum. The residue was purified by flash chromatography.
General procedure GP3 -Cleavage of the acetonide
Trifluoroacetic acid (10 mL/mmol) and water (5 drops) were added at 0 °C to a solution of the acetonide (1.0 equiv) in absolute dichloromethane (10 mL/mmol). The reaction mixture was stirred at this temperature while the reaction progress was monitored by TLC. After complete conversion (2-3 h) the solvent was removed in vacuum without heating the bath, the residue was dissolved in EtOAc (500 mL/mmol), and saturated NaHCO 3 solution (750 mL/mmol) was added. After phase separation the aqueous layer was extracted with EtOAc (3 × 250 mL/mmol).
The combined organic layers were dried over MgSO 4 , filtered and evaporated to dryness in vacuum. The resulting diol was dried under high vacuum and subjected to further reactions without purification.
General procedure GP4 -Synthesis of the cyclic orthoformate
The diol resulting from GP3 and PPTS (2.5 equiv) were dried overnight under high vacuum. Under argon atmosphere absolute dichloromethane (30 mL/mmol) and absolute trimethyl orthoformate (10 mL/mmol) were added. The reaction mixture was 6 stirred for two hours at room temperature while the reaction progress was monitored by TLC or analytical RP-HPLC. The reaction mixture was then filtered through a thin plug of silica gel, which was washed with EtOAc/CH 2 Cl 2 (300 mL, 1:1 v/v). The combined filtrates were evaporated to dryness in vacuum. The resulting cyclic orthoformate was subjected to further conversions after drying under high vacuum without purification.
General procedure GP5 -Synthesis of the bromohydrin formate
The orthoformate (1.0 equiv) was dissolved in absolute CH 2 Cl 2 (15 mL/mmol) and a 0.5 M solution of acetyl bromide in absolute CH 2 Cl 2 (2.5 equiv acetyl bromide) was added. The resulting solution was stirred for four hours at room temperature while the reaction progress was monitored by TLC or analytical RP-HPLC. Subsequently, the reaction mixture was diluted with absolute CH 2 Cl 2 (10 mL) and then poured into an ice-cold mixture of saturated NaHCO 3 solution and ice water (50 mL, 1:1, v/v). The mixture was washed with absolute CH 2 Cl 2 and after phase separation the aqueous layer was extracted with CH 2 Cl 2 (3 × 20 mL). The organic layers were combined, dried over MgSO 4 , filtered and evaporated to dryness. The resulting bromohydrin formate was dried under high vacuum and subjected without further purification to the next reaction step.
General procedure GP6 -Synthesis of the epoxide
To the bromohydrin formate was added under vigorous stirring an emulsion of 0.2 M K 2 CO 3 in ethylene glycol/DME. The reaction mixture was stirred for 3 min and then rapidly diluted with absolute CH 2 Cl 2 (20 mL). was added to the solution, which was heated to 65 °C and ( 2-[(4R,5R)-5-(4-(trifluoromethyl)phenyl)-2,2-dimethyl-1,3-dioxolan The acetonide 21 (31 mg, 0.039 mmol) was converted into the epoxide according to GP3-6 and the crude product was purified by flash chromatography (pentane/EtOAc = 1/3). The purified product was dissolved in CH 3 in the dark at 0 °C. Then, EtOAc (47 mL) and 5% KHSO 4 solution (10 mL, w/v) were added, and the phases were separated. After phase separation, the organic phase was washed with saturated NaHCO 3 solution and brine (10 mL each), dried over 
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